Neurocrine(NBIX) - 2022 Q4 - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2022 Earnings Conference Call February 6, 2023 8:00 AM ET Company Participants Kevin Gorman - CEO Matt Abernethy - CFO Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development and Strategy Officer Todd Tushla - VP of IR Conference Call Participants Paul Matteis - Stifel Neena Bitritto-Garg - Citi Tazeen Ahmad - Bank of America Brian Skorney - Baird Phil Nadeau - Cowen & Company Chris Shibutani - Goldman ...